Savient Pharmaceuticals, Inc. (NASDAQ: SVNT): After last week's success with their gout drug, these shares haven't stopped rising. They reached a new high of $21.36 against 52-week low of $10.58.

Trane Inc. (NYSE: TT): A nice big buy-out from Ingersoll-Rand Company Limited (NYSE: IR) sent shares up to $45.27 from 52-week low of $32.09.

Varian Medical Systems, Inc. (NYSE: VAR): The FDA approved new proton scanning product. The stock Traded up to $52.05 from 52-week low of $37.30.

Coca-Cola Enterprises Inc. (NYSE: CCE): Still moving up after last week's strong forecast. Hit $26.93, up from 52-week low of $18.78.

Douglas A. McIntyre is an editor at 247wallst.com.

The 52-week high club originally appeared on BloggingStocks on Mon, 17 Dec 2007 16:39:00 EST. Please see our terms for use of feeds.

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL): Sees good news on its rheumatoid arthritis drug. Jumps to $26.45 up from 52-week low of $6.64.

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT): Gets strong results from late stage trials for drug which effectively treated patients with gout. Shares move up to $18.58 from 52-week low of $10.58.

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN): FDA approves company's new drug. Stock up to $30.49 and more after hours from 52-week low of $15.53.

Coca-Cola Enterprises Inc. (NYSE: CCE): Has a strong earnings outlook for next year. Moves up to $26.83 from 52-week low of $19.78.

PepsiCo, Inc. (NYSE: PEP): No news. Just a safe, successful place to put money. Up to $78.78 from 52-week low of $61.89.

Douglas A. McIntyre is an editor at 247wallst.com.

The 52-week high club originally appeared on BloggingStocks on Thu, 13 Dec 2007 16:42:00 EST. Please see our terms for use of feeds.

This year has been a stock picker's market extraordinaire! This month's review provides ample evidence of this, as you'll note that Google (NASDAQ: GOOG), which I included for fun because of its popularity, beat all else as a portfolio of one. The average of my seven picks came in second, beating James Cramer's average based on his nine picks. Both Cramer and I beat each of the three indices I am tracking, and therefore beat the average as well, with the largest and most stable, the Standard & Poor's 500 coming in last.

Of course, this could easily change given recent market volatility. A sharp downturn in the market could reverse our fortunes. A lot can happen in the remaining two months -- I take nothing for granted.

While Google shined brightly this year, Cramer and I have each made one pick that shined brighter. Cramer's best, Apple (NASDAQ: AAPL) has gone into orbit this year on the wings of the iPhone, iPod, and growing Mac sales. Benefiting from rising oil prices, shortages in China and the Chinese government allowing a 10% price hike, my PetroChina ADR (NYSE: PTR) has rocketed, becoming the second-largest capitalized company in the world. PTR has done this even in the shadow of Berkshire Hathaway (NYSE: BRK.A) selling its shares and Warren Buffett questioning the huge appreciation of the Chinese stock market and stocks overall.

Continue reading Chasing down 007 picks: AAPL +135%, PTR +85%, GOOG +53%, & VLO +36%

Chasing down 007 picks: AAPL +135%, PTR +85%, GOOG +53%, & VLO +36% originally appeared on BloggingStocks on Fri, 02 Nov 2007 14:10:00 EST. Please see our terms for use of feeds.

Short sellers betting against Cramer picks originally appeared on BloggingStocks on Wed, 27 Jun 2007 20:20:00 EST. Please see our terms for use of feeds.